FDA approves Bristol Myers Squibb’s schizophrenia drug

Cobenfy drug from Bristol Myers Squibb Courtesy: Bristol Myers Squibb The Food and Drug Administration gave approval Thursday Bristol Myers SquibbCobenfy, the highly anticipated schizophrenia drug, is the first novel treatment for the debilitating, chronic mental disorder in more than…